Cargando…

A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cell carcinoma. The myosin 6 (MYO6) plays an important role in tumorigenesis and progression. However, its prognostic and immunological effects in ccRCC have not been comprehensively and systematically studied. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Wei, Chen, Bo, Jiang, Zhaosheng, Cai, Bo, Ma, Limin, Guan, Yangbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493793/ https://www.ncbi.nlm.nih.gov/pubmed/37701098 http://dx.doi.org/10.21037/tcr-23-227

Ejemplares similares

Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker
por: Meng, Wei, et al.
Publicado: (2022)

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma
por: Chao, Xiaoyu, et al.
Publicado: (2021)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
por: Meng, Quan, et al.
Publicado: (2021)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Inhibition of urethral stricture by a catheter loaded with nanoparticle/ pirfenidone complexes
por: Meng, Wei, et al.
Publicado: (2023)

Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis
por: Chang, Peng, et al.
Publicado: (2018)

Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
por: Cheng, Guiyun, et al.
Publicado: (2020)

PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis
por: Chen, Juan, et al.
Publicado: (2021)

The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma
por: Zhou, Yongying, et al.
Publicado: (2021)

Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2022)

Comprehensive analysis of the expression and prognosis of YPEL family members in clear cell renal cell cancer
por: Wang, Lei, et al.
Publicado: (2022)

Decreased Expression of GLYATL1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Deng, Limin, et al.
Publicado: (2023)

Expression signature of six‐snoRNA serves as novel non‐invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma
por: Zhao, Yanyun, et al.
Publicado: (2020)

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2019)

MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma
por: Shi, Lei, et al.
Publicado: (2021)

TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
por: Yan, Youji, et al.
Publicado: (2019)

Inhibition of Ureteral Stricture by Pirfenidone-Loaded Nanoparticle-Coated Ureteral Stents with Slow-Release Pirfenidone
por: Jiang, Zhaosheng, et al.
Publicado: (2022)

A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
por: Xiao, Yongshuang, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma
por: Zhang, Chongli, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
por: Zhu, Yuanyuan, et al.
Publicado: (2021)

Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma
por: Lin, Yongping, et al.
Publicado: (2023)

Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study
por: Lv, Xian-Qiang, et al.
Publicado: (2022)

Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma
por: Tang, Wenbin, et al.
Publicado: (2023)

Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021)

Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses
por: Ren, Xiang-bin, et al.
Publicado: (2021)

Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma
por: You, Yongke, et al.
Publicado: (2021)

Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
por: D'Aniello, Carmine, et al.
Publicado: (2019)

High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wang, Xuegang, et al.
Publicado: (2023)

Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma
por: Cheng, Fajuan, et al.
Publicado: (2021)

Retracted: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2022)

Aberration of lncRNA LINC00460 is a Promising Prognosis Factor and Associated with Progression of Clear Cell Renal Cell Carcinoma
por: Zhang, Shijie, et al.
Publicado: (2021)

Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model
por: Liu, Bin, et al.
Publicado: (2020)

COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA
Publicado: (2013)

VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma
por: Ha, Mihyang, et al.
Publicado: (2019)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

Comprehensive Transcriptomic Analysis of Critical RNA Regulation Associated With Metabolism and Prognosis in Clear Cell Renal Carcinoma
por: Liu, Si, et al.
Publicado: (2021)

Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
por: Zou, Xiong, et al.
Publicado: (2022)

IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Park, Ji Young, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1fm9aiqq8aams7h42iae17m2l1